|22.01.2021||Online Reporting Portal pursuant to the German Transplantation Act is now ready to operate|
|21.01.2021||New Coordinator for the Working Parties of the DGfI|
|18.01.2021||EMA receives Application for Conditional Marketing Authorisation of COVID-19 Vaccine of AstraZeneca|
|06.01.2021||EMA’s Committee for Medicinal Products for Human Use recommends Conditional Marketing Authorisation for Moderna’s COVID-19 Vaccine|
|06.01.2021||European Commission Grants Marketing Authorisation for COVID-19 Vaccine from Moderna for the European Union|
The Paul-Ehrlich-Institut is an Agency of the German Federal Ministry of Health.
Its research and control activities promote the quality, efficacy and safety of biological medicinal products.